Add to ORKGdeacetylase inhibitor entinostat inhibits tumor-initiating cells in triple negative breast cancer cell
Epithelial-to-mesenchymal transition (EMT) in cancer cells facilitates tumor progression by promotin...
Abstract Background A combination of entinostat, all-trans retinoic acid, and doxorubicin (EAD) indu...
Eukaryotic cells maintain an immense amount of genetic information by tightly wrapping their DNA aro...
Mortality following breast cancer diagnosis ismainly due to the development of distant metastasis. T...
The new drug entinostat is a selective histone deacetylase inhibitor with a promising future, since ...
Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. ...
Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. ...
Therapeutic combinations to alter immunosuppressive, solid tumor microenvironments (TME), such as in...
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cell
Inactivating germline mutations in the CDH1 gene (encoding the E-cadherin protein) are the genetic h...
Histone deacetylase inhibitors (HDIs) are a novel class of chemotherapeutics that have potent anti-p...
Objective: Based on promising in vitro and in vivo activity of several histone deacetylase inhibitor...
Chemotherapy modestly prolongs survival of patients with advanced gastric cancer, but strategies are...
Although the combination of radiotherapy and immunotherapy has proven to be effective in lung cancer...
Abstract Background Based on promising phase II data, the histone deacetylase inhibitor entinostat i...
Epithelial-to-mesenchymal transition (EMT) in cancer cells facilitates tumor progression by promotin...
Abstract Background A combination of entinostat, all-trans retinoic acid, and doxorubicin (EAD) indu...
Eukaryotic cells maintain an immense amount of genetic information by tightly wrapping their DNA aro...
Mortality following breast cancer diagnosis ismainly due to the development of distant metastasis. T...
The new drug entinostat is a selective histone deacetylase inhibitor with a promising future, since ...
Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. ...
Immunosuppressive factors such as regulatory T cells (Tregs) limit the efficacy of immunotherapies. ...
Therapeutic combinations to alter immunosuppressive, solid tumor microenvironments (TME), such as in...
Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cell
Inactivating germline mutations in the CDH1 gene (encoding the E-cadherin protein) are the genetic h...
Histone deacetylase inhibitors (HDIs) are a novel class of chemotherapeutics that have potent anti-p...
Objective: Based on promising in vitro and in vivo activity of several histone deacetylase inhibitor...
Chemotherapy modestly prolongs survival of patients with advanced gastric cancer, but strategies are...
Although the combination of radiotherapy and immunotherapy has proven to be effective in lung cancer...
Abstract Background Based on promising phase II data, the histone deacetylase inhibitor entinostat i...
Epithelial-to-mesenchymal transition (EMT) in cancer cells facilitates tumor progression by promotin...
Abstract Background A combination of entinostat, all-trans retinoic acid, and doxorubicin (EAD) indu...
Eukaryotic cells maintain an immense amount of genetic information by tightly wrapping their DNA aro...